Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A-375 | Vemurafenib | Saracatinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 6145 | 245 | 0.3089 | 0.3648 | 0.0399 | 0.0413 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 3 | 1115 | 1046 | 0.0099 | 0.0097 | 0.9381 | 0.9430 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 1231 | 1160 | 0.0101 | 0.0097 | 0.9423 | 0.9430 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 1 | 1247 | 1183 | 0.0091 | 0.0097 | 0.9487 | 0.9430 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 1114 | 238 | 0.0459 | 0.0453 | 0.2136 | 0.2134 |
COLO 858 | Vemurafenib | Dasatinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 2351 | 292 | 0.2941 | 0.3076 | 0.1242 | 0.1502 |
COLO 858 | Vemurafenib | Defactinib | 0.316 | 3.160 | uM | 72 | hr | 1 | 1059 | 843 | 0.0256 | 0.0309 | 0.7960 | 0.7785 |
COLO 858 | Vemurafenib | Defactinib | 3.160 | 3.160 | uM | 72 | hr | 1 | 921 | 884 | 0.0044 | 0.0047 | 0.9598 | 0.9535 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 1 | 5745 | 285 | 0.3434 | 0.2974 | 0.0496 | 0.0491 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 2 | 1554 | 62 | 0.0781 | 0.0757 | 0.0399 | 0.0403 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 1 | 3954 | 69 | 0.2034 | 0.1687 | 0.0175 | 0.0176 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 2 | 3199 | 50 | 0.1648 | 0.1687 | 0.0156 | 0.0176 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 3 | 2686 | 53 | 0.1378 | 0.1687 | 0.0197 | 0.0176 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 3 | 3476 | 189 | 0.2068 | 0.2974 | 0.0544 | 0.0491 |
COLO 858 | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 1 | 1128 | 750 | 0.0640 | 0.0618 | 0.6649 | 0.6473 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 3 | 1316 | 53 | 0.0661 | 0.0757 | 0.0403 | 0.0403 |
COLO 858 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 2 | 1666 | 709 | 0.1136 | 0.1023 | 0.4256 | 0.4297 |
COLO 858 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 1 | 1609 | 714 | 0.1063 | 0.1023 | 0.4438 | 0.4297 |
COLO 858 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 1265 | 531 | 0.0871 | 0.1023 | 0.4198 | 0.4297 |
COLO 858 | Vemurafenib | Saracatinib | 1.000 | 3.160 | uM | 72 | hr | 2 | 1025 | 921 | 0.0176 | 0.0171 | 0.8985 | 0.8905 |
A-375 | Vemurafenib | Dasatinib | 0.316 | 3.160 | uM | 72 | hr | 1 | 1388 | 90 | 0.0657 | 0.0636 | 0.0648 | 0.0545 |
COLO 858 | Vemurafenib | Defactinib | 0.100 | 3.160 | uM | 72 | hr | 2 | 1411 | 883 | 0.0627 | 0.0598 | 0.6258 | 0.6178 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 1 | 1649 | 67 | 0.0828 | 0.0757 | 0.0406 | 0.0403 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 3.160 | uM | 72 | hr | 2 | 572 | 111 | 0.4668 | 0.4489 | 0.1941 | 0.1849 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 3.160 | uM | 72 | hr | 1 | 642 | 104 | 0.5447 | 0.4489 | 0.1620 | 0.1849 |